Stifel Financial Corp Has $2.41 Million Holdings in Privia Health Group, Inc. (NASDAQ:PRVA)

Stifel Financial Corp trimmed its position in Privia Health Group, Inc. (NASDAQ:PRVA) by 2.7% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 132,044 shares of the company’s stock after selling 3,685 shares during the quarter. Stifel Financial Corp owned approximately 0.11% of Privia Health Group worth $2,405,000 at the end of the most recent quarter.

Other institutional investors have also made changes to their positions in the company. Quarry LP lifted its position in shares of Privia Health Group by 344.6% in the 3rd quarter. Quarry LP now owns 3,268 shares of the company’s stock valued at $60,000 after acquiring an additional 2,533 shares in the last quarter. Centiva Capital LP lifted its holdings in shares of Privia Health Group by 102.6% in the third quarter. Centiva Capital LP now owns 41,614 shares of the company’s stock valued at $758,000 after purchasing an additional 21,073 shares in the last quarter. Benjamin Edwards Inc. raised its position in Privia Health Group by 360.7% during the third quarter. Benjamin Edwards Inc. now owns 14,366 shares of the company’s stock valued at $262,000 after buying an additional 11,248 shares during the period. Eventide Asset Management LLC lifted its stake in Privia Health Group by 979.2% in the 3rd quarter. Eventide Asset Management LLC now owns 822,438 shares of the company’s stock worth $14,977,000 after acquiring an additional 746,231 shares in the last quarter. Finally, Quantbot Technologies LP boosted its position in Privia Health Group by 82.6% during the 3rd quarter. Quantbot Technologies LP now owns 37,375 shares of the company’s stock worth $681,000 after acquiring an additional 16,904 shares during the period. 94.48% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

A number of equities analysts have recently weighed in on PRVA shares. Barclays upped their target price on Privia Health Group from $19.00 to $21.00 and gave the company an “equal weight” rating in a report on Friday, November 8th. Truist Financial raised their price target on shares of Privia Health Group from $24.00 to $27.00 and gave the company a “buy” rating in a report on Friday, November 8th. KeyCorp began coverage on shares of Privia Health Group in a report on Friday, October 11th. They issued an “overweight” rating and a $23.00 price objective for the company. JPMorgan Chase & Co. raised their target price on Privia Health Group from $27.00 to $28.00 and gave the company an “overweight” rating in a report on Friday, November 29th. Finally, Macquarie initiated coverage on Privia Health Group in a report on Monday. They issued an “outperform” rating and a $25.00 target price for the company. Two investment analysts have rated the stock with a hold rating, twelve have assigned a buy rating and two have issued a strong buy rating to the company. According to MarketBeat.com, the stock currently has an average rating of “Buy” and a consensus target price of $24.80.

Privia Health Group Stock Performance

NASDAQ PRVA opened at $20.34 on Thursday. Privia Health Group, Inc. has a twelve month low of $15.92 and a twelve month high of $24.30. The stock has a market cap of $2.44 billion, a PE ratio of 203.42, a PEG ratio of 5.45 and a beta of 0.83. The firm has a 50-day simple moving average of $20.19 and a 200 day simple moving average of $19.11.

Privia Health Group Profile

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.